ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

ClinicalTrials.gov ID: NCT06312020

Public ClinicalTrials.gov record NCT06312020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjögren's Syndrome

Study identification

NCT ID
NCT06312020
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
209 participants

Conditions and interventions

Interventions

  • HZN-1116 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2024
Primary completion
Mar 18, 2026
Completion
Nov 23, 2026
Last update posted
Oct 23, 2025

2024 – 2026

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research-S Vineyard Ave Mesa Arizona 85210-6871
Arizona Arthritis and Rheumatology Associates -4550 E Bell Rd Phoenix Arizona 85032-9306
Neurovations Research Napa California 94558-2415
Life Arc Research Centers Corp Miami Florida 33126
IRIS Research and Development LLC Plantation Florida 33324-2736
Clinical Research of West Florida Inc - Tampa Tampa Florida 33606-1246
Augusta University Medical Center-Augusta-1120 15th St Augusta Georgia 30912-0004
Tufts Medical Center - 800 Washington St - PPDS Boston Massachusetts 02111-1552
Pioneer Clinical Research NY New York New York 10016-7313
DJL Clinical Research PLLC-431 N Wendover Rd Charlotte North Carolina 28211-1064
Altoona Center for Clinical Research - 175 Meadowbrook Ln Duncansville Pennsylvania 16635-8445
West Tennessee Research Institute Jackson Tennessee 38305-2883
Tekton Research, LLC - W Gate Blvd - Austin - PPDS Austin Texas 78745
Prolato Clinical Research Center Houston Texas 77054-2853
R & H Clinical Research-777 S Fry Rd Katy Texas 77450-2297
University Of Wisconsin - Madison Madison Wisconsin 53792-0001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06312020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06312020 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →